FRM
ITCI
Fox Run Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,667
| Closed | -$1.39M | – | 1293 |
|
|
2024
Q4 | $1.39M | Buy |
+16,667
| New | +$1.39M | 0.25% | 72 |
|
|
2024
Q3 | – | Sell |
-18,575
| Closed | -$1.27M | – | 1169 |
|
|
2024
Q2 | $1.27M | Buy |
+18,575
| New | +$1.27M | 0.24% | 111 |
|
|
2024
Q1 | – | Sell |
-3,289
| Closed | -$236K | – | 1119 |
|
|
2023
Q4 | $236K | Buy |
+3,289
| New | +$236K | 0.06% | 584 |
|
|
2022
Q4 | – | Sell |
-8,357
| Closed | -$389K | – | 936 |
|
|
2022
Q3 | $389K | Sell |
8,357
-359
| -4% | -$16.7K | 0.15% | 261 |
|
|
2022
Q2 | $498K | Buy |
+8,716
| New | +$498K | 0.25% | 120 |
|
|
2020
Q4 | – | Sell |
-10,882
| Closed | -$279K | – | 303 |
|
|
2020
Q3 | $279K | Buy |
+10,882
| New | +$279K | 0.7% | 50 |
|
|
2018
Q4 | – | Sell |
-10,109
| Closed | -$219K | – | 780 |
|
|
2018
Q3 | $219K | Sell |
10,109
-20,053
| -66% | -$434K | 0.1% | 455 |
|
|
2018
Q2 | $533K | Buy |
+30,162
| New | +$533K | 0.17% | 217 |
|
|
2018
Q1 | – | Sell |
-26,625
| Closed | -$386K | – | 967 |
|
|
2017
Q4 | $386K | Buy |
26,625
+1,925
| +8% | +$27.9K | 0.11% | 374 |
|
|
2017
Q3 | $390K | Buy |
+24,700
| New | +$390K | 0.11% | 387 |
|
|
2017
Q1 | – | Sell |
-15,300
| Closed | -$231K | – | 780 |
|
|
2016
Q4 | $231K | Buy |
+15,300
| New | +$231K | 0.12% | 390 |
|
|
2016
Q3 | – | Sell |
-8,200
| Closed | -$318K | – | 728 |
|
|
2016
Q2 | $318K | Buy |
+8,200
| New | +$318K | 0.15% | 268 |
|